AstraZeneca Pharmaceuticals LP - Form 483, 2024-06-07
Document Details
![FDA 483 - AstraZeneca Pharmaceuticals LP [Frederick / United States of America] - Download PDF - Redica Systems](https://redicadocstoreprod.blob.core.windows.net/images/100187821.png)
Experience Redica Systems’ NEW AI document analysis for 483 documents and observations
Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering over 900,000 inspection records, over 62,000 documents, and over 141,000 searchable observations.
The interactive 483 element below is not an example of the specific 483 highlighted at the top of this page.
If you just need this specific document, you can quickly add it to your cart and check out. On the other hand, if you’d like to experience the full analytical functionality of Redica Systems, fill out the form below to get in touch with our Sales Team.
Ready to get your hands on our new AI analyzed documents?
Loading...
FDA 483’s Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of FDA 483 documents, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more